Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
City of Hope Medical Center
Rhizen Pharmaceuticals SA
National Cancer Institute (NCI)
University of Texas Southwestern Medical Center
Celgene
Celgene
Celgene
Celgene
Celgene
Fondazione Italiana Linfomi - ETS
Celgene
Takeda
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Cancer Institute (NCI)